These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 18546855)

  • 21. Localization of primary prostate cancer with dual-phase 18F-fluorocholine PET.
    Kwee SA; Wei H; Sesterhenn I; Yun D; Coel MN
    J Nucl Med; 2006 Feb; 47(2):262-9. PubMed ID: 16455632
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Imaging prostate cancer with 11C-choline PET/CT.
    Reske SN; Blumstein NM; Neumaier B; Gottfried HW; Finsterbusch F; Kocot D; Möller P; Glatting G; Perner S
    J Nucl Med; 2006 Aug; 47(8):1249-54. PubMed ID: 16883001
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [ROLE OF KINETIC PERFORMANCE OF PSA IN SELECTION OF THE PATIENTS FOR CONDUCTION OF 11C-CHOLINE PET/CT AIMED TO REVEAL LOCAL RECURRENCES OF PROSTATE CANCER].
    Rybalov MA; De Iong IY; Breusma AI; Al'-Shukri SKh; Borovets SY
    Vestn Khir Im I I Grek; 2015; 174(6):25-8. PubMed ID: 27066654
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Detection of Bone Metastases Using 11C-Acetate PET in Patients with Prostate Cancer with Biochemical Recurrence.
    Spick C; Polanec SH; Mitterhauser M; Wadsak W; Anner P; Reiterits B; Haug AR; Hacker M; Beheshti M; Karanikas G
    Anticancer Res; 2015 Dec; 35(12):6787-91. PubMed ID: 26637897
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 11C-acetate PET imaging of prostate cancer: detection of recurrent disease at PSA relapse.
    Oyama N; Miller TR; Dehdashti F; Siegel BA; Fischer KC; Michalski JM; Kibel AS; Andriole GL; Picus J; Welch MJ
    J Nucl Med; 2003 Apr; 44(4):549-55. PubMed ID: 12679398
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 11C-choline positron emission tomography/computerized tomography for tumor localization of primary prostate cancer in comparison with 12-core biopsy.
    Martorana G; Schiavina R; Corti B; Farsad M; Salizzoni E; Brunocilla E; Bertaccini A; Manferrari F; Castellucci P; Fanti S; Canini R; Grigioni WF; D'Errico Grigioni A
    J Urol; 2006 Sep; 176(3):954-60; discussion 960. PubMed ID: 16890665
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Contribution of 11C-choline positron emission tomography/computerized tomography to preoperative staging of advanced transitional cell carcinoma.
    Gofrit ON; Mishani E; Orevi M; Klein M; Freedman N; Pode D; Shapiro A; Katz R; Libson E; Chisin R
    J Urol; 2006 Sep; 176(3):940-4; discussion 944. PubMed ID: 16890661
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Experience with carbon-11 choline positron emission tomography in prostate carcinoma.
    Kotzerke J; Prang J; Neumaier B; Volkmer B; Guhlmann A; Kleinschmidt K; Hautmann R; Reske SN
    Eur J Nucl Med; 2000 Sep; 27(9):1415-9. PubMed ID: 11007527
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Pro and contra: 11C choline PET in diagnosis of prostate cancer].
    Kotzerke J; Zöphel K; Salomon G; Graefen M; Heidenreich A
    Aktuelle Urol; 2007 May; 38(3):189-94. PubMed ID: 17566231
    [No Abstract]   [Full Text] [Related]  

  • 30. Detection of pelvic lymph node metastases in patients with clinically localized prostate cancer: comparison of [18F]fluorocholine positron emission tomography-computerized tomography and laparoscopic radioisotope guided sentinel lymph node dissection.
    Häcker A; Jeschke S; Leeb K; Prammer K; Ziegerhofer J; Sega W; Langsteger W; Janetschek G
    J Urol; 2006 Nov; 176(5):2014-8; discussion 2018-9. PubMed ID: 17070241
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intraindividual comparison of [11C]acetate and [11C]choline PET for detection of metastases of prostate cancer.
    Kotzerke J; Volkmer BG; Glatting G; van den Hoff J; Gschwend JE; Messer P; Reske SN; Neumaier B
    Nuklearmedizin; 2003 Feb; 42(1):25-30. PubMed ID: 12601451
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Visualization of prostate cancer with 11C-choline positron emission tomography.
    de Jong IJ; Pruim J; Elsinga PH; Vaalburg W; Mensink HJ
    Eur Urol; 2002 Jul; 42(1):18-23. PubMed ID: 12121724
    [TBL] [Abstract][Full Text] [Related]  

  • 33. PET/CT and choline: diagnosis and staging.
    Farsad M; Schwarzenböck S; Krause BJ
    Q J Nucl Med Mol Imaging; 2012 Aug; 56(4):343-53. PubMed ID: 23013664
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [11C]-choline PET/CT in imaging locally advanced prostate cancer.
    Rodari M; Lopci E; Pepe G; Antunovic L; Chiti A
    Nucl Med Rev Cent East Eur; 2011; 14(2):118-9. PubMed ID: 22219155
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Carbon-11 acetate positron emission tomography can detect local recurrence of prostate cancer.
    Kotzerke J; Volkmer BG; Neumaier B; Gschwend JE; Hautmann RE; Reske SN
    Eur J Nucl Med Mol Imaging; 2002 Oct; 29(10):1380-4. PubMed ID: 12271422
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The (11C) acetate positron emission tomography in prostatic carcinoma. New prospects in metabolic imaging].
    Hautzel H; Müller-Mattheis V; Herzog H; Roden W; Coenen HH; Ackermann R; Müller-Gärtner HW; Krause BJ
    Urologe A; 2002 Nov; 41(6):569-76. PubMed ID: 12524944
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Focus: Prostate cancer and PET-choline].
    Brenot-Rossi I
    Prog Urol; 2014 Jan; 24(1):3-8. PubMed ID: 24365622
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Application of C-11-acetate positron-emission tomography (PET) imaging in prostate cancer: systematic review and meta-analysis of the literature.
    Mohsen B; Giorgio T; Rasoul ZS; Werner L; Ali GR; Reza DK; Ramin S
    BJU Int; 2013 Dec; 112(8):1062-72. PubMed ID: 23937453
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Detection of prostate cancer with 11C-methionine positron emission tomography.
    Tóth G; Lengyel Z; Balkay L; Salah MA; Trón L; Tóth C
    J Urol; 2005 Jan; 173(1):66-9; discussion 69. PubMed ID: 15592030
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A case of multimodality multiparametric 11C-choline PET/MR for biopsy targeting in prior biopsy-negative primary prostate cancer.
    Takei T; Souvatzoglou M; Beer AJ; Drzezga A; Ziegler S; Rummeny EJ; Schwaiger M; Eiber M
    Clin Nucl Med; 2012 Sep; 37(9):918-9. PubMed ID: 22889793
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.